Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileTorunn I. Yock, M.D., M.Ch.

TitleAssociate Professor of Radiation Oncology
InstitutionMassachusetts General Hospital
DepartmentRadiation Oncology
AddressMassachusetts General Hospital
Radiation Oncology, Cox 341
100 Blossom Street
Boston MA 02114
Phone617/726-3603
vCardDownload vCard (login for email)

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. McEvoy M, Robison N, Manley P, Yock T, Konopka K, Brown RE, Wolff J, Green AL. Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma. J Pediatr Hematol Oncol. 2017 Aug 30. PMID: 28859040.
    View in: PubMed
  2. Baedorf Kassis S, Gallotto SL, Hess CB, Weyman E, Yock TI. Rethinking reconsent when minors reach adult age in minimal risk studies. Pediatr Blood Cancer. 2017 Jul 27. PMID: 28748629.
    View in: PubMed
  3. Berrington de Gonzalez A, Vikram B, Buchsbaum JC, de Vathaire F, Dörr W, Hass-Kogan D, Langendijk JA, Mahajan A, Newhauser W, Ottolenghi A, Ronckers C, Schulte R, Walsh L, Yock TI, Kleinerman RA. A Clarion Call for Large-Scale Collaborative Studies of Pediatric Proton Therapy. Int J Radiat Oncol Biol Phys. 2017 Aug 01; 98(5):980-981. PMID: 28721911.
    View in: PubMed
  4. Ermoian RP, Breneman J, Walterhouse DO, Chi YY, Meza J, Anderson J, Hawkins DS, Hayes-Jordan AA, Parham DM, Yock TI, Donaldson SS, Wolden SL. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2017 Sep; 64(9). PMID: 28548706.
    View in: PubMed
  5. Giantsoudi D, Seco J, Eaton BR, Simeone FJ, Kooy H, Yock TI, Tarbell NJ, DeLaney TF, Adams J, Paganetti H, MacDonald SM. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):37-46. PMID: 28587051.
    View in: PubMed
  6. Mouw KW, Yeap BY, Caruso P, Fay A, Misra M, Sethi RV, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Freitag SK, Munzenrider JE, Grabowski E, Katz M, Kuhlthau K, DeCastro D, Heidary G, Ciralsky J, Mukai S, Shih HA. Analysis of patient outcomes following proton radiation therapy for retinoblastoma. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):44-52. PMID: 28607957.
    View in: PubMed
  7. Gondi V, Yock TI, Mehta MP. Proton therapy for paediatric CNS tumours - improving treatment-related outcomes. Nat Rev Neurol. 2016 Jun; 12(6):334-45. PMID: 27197578.
    View in: PubMed
  8. Yock TI, Tarbell NJ, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 May; 17(5):e174-5. PMID: 27301036.
    View in: PubMed
  9. Bass JK, Knight KR, Yock TI, Chang KW, Cipkala D, Grewal SS. Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Jul; 63(7):1152-62. PMID: 26928933.
    View in: PubMed
  10. Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-98. PMID: 26830377.
    View in: PubMed
  11. Moteabbed M, Yock TI, Depauw N, Madden TM, Kooy HM, Paganetti H. Impact of Spot Size and Beam-Shaping Devices on the Treatment Plan Quality for Pencil Beam Scanning Proton Therapy. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):190-8. PMID: 27084640; PMCID: PMC4834139 [Available on 05/01/17].
  12. Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 Jun; 18(6):881-7. PMID: 26688075; PMCID: PMC4864263 [Available on 06/01/17].
  13. Eaton BR, MacDonald SM, Yock TI, Tarbell NJ. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015; 5:261. PMID: 26636040; PMCID: PMC4659915.
  14. Geng C, Moteabbed M, Xie Y, Schuemann J, Yock T, Paganetti H. Assessing the radiation-induced second cancer risk in proton therapy for pediatric brain tumors: the impact of employing a patient-specific aperture in pencil beam scanning. Phys Med Biol. 2016 Jan 07; 61(1):12-22. PMID: 26605679.
    View in: PubMed
  15. Giantsoudi D, Sethi RV, Yeap BY, Eaton BR, Ebb DH, Caruso PA, Rapalino O, Chen YL, Adams JA, Yock TI, Tarbell NJ, Paganetti H, MacDonald SM. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):287-96. PMID: 26691786.
    View in: PubMed
  16. Eaton BR, Esiashvili N, Kim S, Weyman EA, Thornton LT, Mazewski C, MacDonald T, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):133-8. PMID: 26700707; PMCID: PMC4692186 [Available on 01/01/17].
  17. Eaton BR, Chowdhry V, Weaver K, Liu L, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Use of proton therapy for re-irradiation in pediatric intracranial ependymoma. Radiother Oncol. 2015 Aug; 116(2):301-8. PMID: 26243681.
    View in: PubMed
  18. Pulsifer MB, Sethi RV, Kuhlthau KA, MacDonald SM, Tarbell NJ, Yock TI. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):400-7. PMID: 26254679; PMCID: PMC4955513 [Available on 10/01/16].
  19. Moteabbed M, Depauw N, Kooy H, Yock T, Paganetti H. SU-F-BRD-12: When Does Pencil Beam Scanning Become Superior to Passive Scattered Proton Therapy for Pediatric Head and Neck Cancers? Med Phys. 2015 Jun; 42(6):3528. PMID: 26128492.
    View in: PubMed
  20. Matuszak M, Moran J, Xiao Y, Mayo C, Bosch W, Popple R, Marks L, Wu Q, Molineu A, Miller R, Yock T, McNutt T, Brown N, Purdie T, Yorke E, Santanam L, Gabriel P, Michalski J, Moore J, Richardson S, Siochi R, Napalitano M, Ulin K, Fitzgerald T, Feng M, Verbakel W, Siddiqui S, Morgas T, Martel M, Archambault Y, Ladra M, Lansing B, Ruo R, Fogliata-Cozzi A, Hurkmans C. SU-E-P-22: AAPM Task Group 263 Tackling Standardization of Nomenclature for Radiation Therapy. Med Phys. 2015 Jun; 42(6):3231. PMID: 26127263.
    View in: PubMed
  21. Ladra MM, Mandeville HC, Niemierko A, Padera TP, Friedmann AM, MacDonald SM, Ebb D, Chen YL, Tarbell NJ, Yock TI. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):358-67. PMID: 25864172.
    View in: PubMed
  22. Lucas JT, Ladra MM, MacDonald SM, Busse PM, Friedmann AM, Ebb DH, Marcus KJ, Tarbell NJ, Yock TI. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8. PMID: 25820437.
    View in: PubMed
  23. Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015 May 15; 121(10):1694-702. PMID: 25641407.
    View in: PubMed
  24. Kuhlthau K, Luff D, Delahaye J, Wong A, Yock T, Huang M, Park ER. Health-Related Quality of Life of Adolescent and Young Adult Survivors of Central Nervous System Tumors: Identifying Domains From a Survivor Perspective. J Pediatr Oncol Nurs. 2015 Nov-Dec; 32(6):385-93. PMID: 25616371.
    View in: PubMed
  25. Kuo AH, Ancukiewicz M, Kozak KR, Yock TI, Padera TP. Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation. Radiat Oncol. 2015 Jan 09; 10:5. PMID: 25573181; PMCID: PMC4293110.
  26. Min CH, Paganetti H, Winey BA, Adams J, MacDonald SM, Tarbell NJ, Yock TI. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation. Radiat Oncol. 2014 Nov 18; 9:220. PMID: 25403752; PMCID: PMC4251676.
  27. Eaton BR, Yock T. The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J. 2014 Nov-Dec; 20(6):403-8. PMID: 25415686.
    View in: PubMed
  28. Ladra MM, Szymonifka JD, Mahajan A, Friedmann AM, Yong Yeap B, Goebel CP, MacDonald SM, Grosshans DR, Rodriguez-Galindo C, Marcus KJ, Tarbell NJ, Yock TI. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70. PMID: 25332253; PMCID: PMC4226806.
  29. Ladra MM, Edgington SK, Mahajan A, Grosshans D, Szymonifka J, Khan F, Moteabbed M, Friedmann AM, MacDonald SM, Tarbell NJ, Yock TI. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol. 2014 Oct; 113(1):77-83. PMID: 25443861; PMCID: PMC4298831.
  30. Yock TI, Bhat S, Szymonifka J, Yeap BY, Delahaye J, Donaldson SS, MacDonald SM, Pulsifer MB, Hill KS, DeLaney TF, Ebb D, Huang M, Tarbell NJ, Fisher PG, Kuhlthau KA. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014 Oct; 113(1):89-94. PMID: 25304720; PMCID: PMC4288853.
  31. Yock TI, Constine LS, Mahajan A. Protons, the brainstem, and toxicity: ingredients for an emerging dialectic. Acta Oncol. 2014 Oct; 53(10):1279-82. PMID: 25327262.
    View in: PubMed
  32. Mouw KW, Sethi RV, Yeap BY, MacDonald SM, Chen YL, Tarbell NJ, Yock TI, Munzenrider JE, Adams J, Grabowski E, Mukai S, Shih HA. Proton radiation therapy for the treatment of retinoblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):863-9. PMID: 25227498; PMCID: PMC4253018.
  33. Greenberger BA, Pulsifer MB, Ebb DH, MacDonald SM, Jones RM, Butler WE, Huang MS, Marcus KJ, Oberg JA, Tarbell NJ, Yock TI. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-8. PMID: 25035209.
    View in: PubMed
  34. Moteabbed M, Yock TI, Paganetti H. The risk of radiation-induced second cancers in the high to medium dose region: a comparison between passive and scanned proton therapy, IMRT and VMAT for pediatric patients with brain tumors. Phys Med Biol. 2014 Jun 21; 59(12):2883-99. PMID: 24828559.
    View in: PubMed
  35. Sethi RV, Giantsoudi D, Raiford M, Malhi I, Niemierko A, Rapalino O, Caruso P, Yock TI, Tarbell NJ, Paganetti H, MacDonald SM. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):655-63. PMID: 24521681.
    View in: PubMed
  36. Zwagerman NT, Foster K, Jakacki R, Khan FH, Yock TI, Greene S. The development of Moyamoya syndrome after proton beam therapy. Pediatr Blood Cancer. 2014 Aug; 61(8):1490-2. PMID: 24501091.
    View in: PubMed
  37. Ladra MM, Yock TI. Proton radiotherapy for pediatric sarcoma. Cancers (Basel). 2014 Jan 14; 6(1):112-27. PMID: 24424260; PMCID: PMC3980591.
  38. Hagendoorn J, Yock TI, Borel Rinkes IH, Padera TP, Ebb DH. Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer. 2014 Mar; 61(3):401-6. PMID: 24214028; PMCID: PMC4123459.
  39. Macdonald SM, Sethi R, Lavally B, Yeap BY, Marcus KJ, Caruso P, Pulsifer M, Huang M, Ebb D, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9. PMID: 24101739; PMCID: PMC3813421.
  40. Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, Munzenrider JE, Grabowski E, Rodriguez-Galindo C, Yock TI, Tarbell NJ, Marcus KJ, Mukai S, MacDonald SM. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014 Jan 01; 120(1):126-33. PMID: 24122173; PMCID: PMC3959122.
  41. Aizer AA, Ancukiewicz M, Nguyen PL, Macdonald SM, Yock TI, Tarbell NJ, Shih HA, Loeffler JS, Oh KS. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol. 2013 Dec; 115(3):411-9. PMID: 24057324.
    View in: PubMed
  42. Mailhot Vega RB, Kim J, Bussière M, Hattangadi J, Hollander A, Michalski J, Tarbell NJ, Yock T, MacDonald SM. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013 Dec 15; 119(24):4299-307. PMID: 24105630.
    View in: PubMed
  43. Sethi RV, Marino R, Niemierko A, Tarbell NJ, Yock TI, MacDonald SM. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. 2013 Nov; 163(5):1448-53. PMID: 23896184.
    View in: PubMed
  44. Tarbell NJ, Friedman H, Polkinghorn WR, Yock T, Zhou T, Chen Z, Burger P, Barnes P, Kun L. High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031). J Clin Oncol. 2013 Aug 10; 31(23):2936-41. PMID: 23857975; PMCID: PMC3732312.
  45. Jimenez RB, Sethi R, Depauw N, Pulsifer MB, Adams J, McBride SM, Ebb D, Fullerton BC, Tarbell NJ, Yock TI, Macdonald SM. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):120-6. PMID: 23790826.
    View in: PubMed
  46. Chung CS, Yock TI, Nelson K, Xu Y, Keating NL, Tarbell NJ. Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):46-52. PMID: 23778197.
    View in: PubMed
  47. Moteabbed M, Yock T, Paganetti H. TU-A-108-10: Pencil Beam Scanning Vs. Passive Scattered Proton Therapy for Pediatric Thoracic/pelvic Cancers. Med Phys. 2013 Jun; 40(6Part25):421. PMID: 28518880.
    View in: PubMed
  48. Friedmann AM, Wolfson JA, Hudson MM, Weinstein HJ, Link MP, Billett A, Larsen EC, Yock T, Donaldson SS, Marcus K, Krasin MJ, Howard SC, Metzger ML. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy. Pediatr Blood Cancer. 2013 Sep; 60(9):1458-63. PMID: 23677874; PMCID: PMC4313350.
  49. Aizer AA, Sethi RV, Hedley-Whyte ET, Ebb D, Tarbell NJ, Yock TI, Macdonald SM. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications. Neuro Oncol. 2013 Jul; 15(7):955-60. PMID: 23640532; PMCID: PMC3688019.
  50. De Amorim Bernstein K, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, MacDonald SM. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):114-20. PMID: 23498870.
    View in: PubMed
  51. Kozak KR, Milne GL, Bentzen SM, Yock TI. Elevation of prostaglandin E2 in lung cancer patients with digital clubbing. J Thorac Oncol. 2012 Dec; 7(12):1877-8. PMID: 22024643; PMCID: PMC3371124.
  52. Yock TI, Caruso PA. Risk of second cancers after photon and proton radiotherapy: a review of the data. Health Phys. 2012 Nov; 103(5):577-85. PMID: 23032887.
    View in: PubMed
  53. Paganetti H, Athar BS, Moteabbed M, A Adams J, Schneider U, Yock TI. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field. Phys Med Biol. 2012 Oct 07; 57(19):6047-61. PMID: 22968191.
    View in: PubMed
  54. Metzger ML, Weinstein HJ, Hudson MM, Billett AL, Larsen EC, Friedmann A, Howard SC, Donaldson SS, Krasin MJ, Kun LE, Marcus KJ, Yock TI, Tarbell N, Billups CA, Wu J, Link MP. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012 Jun 27; 307(24):2609-16. PMID: 22735430; PMCID: PMC3526806.
  55. Paganetti H, Moteabbed M, Athar B, Adams J, Schneider U, Yock T. SU-E-T-258: Assessment of Radiation Induced Second Cancer Risks in Proton Therapy and IMRT for Organs inside the Main Radiation Field. Med Phys. 2012 Jun; 39(6Part13):3762-3763. PMID: 28517309.
    View in: PubMed
  56. Narayan A, Carriero NJ, Gettinger SN, Kluytenaar J, Kozak KR, Yock TI, Muscato NE, Ugarelli P, Decker RH, Patel AA. Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res. 2012 Jul 15; 72(14):3492-8. PMID: 22581825; PMCID: PMC3426449.
  57. Kuhlthau KA, Pulsifer MB, Yeap BY, Rivera Morales D, Delahaye J, Hill KS, Ebb D, Abrams AN, Macdonald SM, Tarbell NJ, Yock TI. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10; 30(17):2079-86. PMID: 22565004; PMCID: PMC3397695.
  58. Houtrow AJ, Yock TI, Delahaye J, Kuhlthau K. The family impacts of proton radiation therapy for children with brain tumors. J Pediatr Oncol Nurs. 2012 May-Jun; 29(3):171-9. PMID: 22647729; PMCID: PMC3587352.
  59. Cotter SE, McBride SM, Yock TI. Proton radiotherapy for solid tumors of childhood. Technol Cancer Res Treat. 2012 Jun; 11(3):267-78. PMID: 22417062; PMCID: PMC4527470.
  60. Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, Plastaras J, Bucci MK, Yock TI, Bonilla L, Price R, Harris EE, Konski AA. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol. 2012 Apr; 103(1):8-11. PMID: 22405807.
    View in: PubMed
  61. Hattangadi JA, Rombi B, Yock TI, Broussard G, Friedmann AM, Huang M, Chen YL, Lu HM, Kooy H, MacDonald SM. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):1015-22. PMID: 22138463.
    View in: PubMed
  62. Hattangadi J, Esty B, Winey B, Duigenan S, Huang M, Yock T. Radiation recall myositis in pediatric Ewing sarcoma. Pediatr Blood Cancer. 2012 Sep; 59(3):570-2. PMID: 22021129.
    View in: PubMed
  63. Rombi B, DeLaney TF, MacDonald SM, Huang MS, Ebb DH, Liebsch NJ, Raskin KA, Yeap BY, Marcus KJ, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8. PMID: 21856094.
    View in: PubMed
  64. Metzger M, Weinstein HJ, Hudson MM, Billett A, Larsen EC, Friedmann AM, Donaldson SS, Krasin MJ, Kun LE, Marcus KC, Yock TI, Tarbell N, Billups C, Wu J, Link MP. Results of a prospective clinical trial for VAMP alone without irradiation for pediatric favorable, early-stage Hodgkin lymphoma patients who achieve an early complete response. J Clin Oncol. 2011 May 20; 29(15_suppl):9503. PMID: 28019832.
    View in: PubMed
  65. Ciernik IF, Niemierko A, Harmon DC, Kobayashi W, Chen YL, Yock TI, Ebb DH, Choy E, Raskin KA, Liebsch N, Hornicek FJ, Delaney TF. Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer. 2011 Oct 01; 117(19):4522-30. PMID: 21448934; PMCID: PMC3716000.
  66. Childs SK, Kozak KR, Friedmann AM, Yeap BY, Adams J, MacDonald SM, Liebsch NJ, Tarbell NJ, Yock TI. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):635-42. PMID: 21377294; PMCID: PMC3290917.
  67. Cotter SE, Herrup DA, Friedmann A, Macdonald SM, Pieretti RV, Robinson G, Adams J, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1367-73. PMID: 20934266.
    View in: PubMed
  68. Huh WW, Anderson JR, Rodeberg D, Teot L, Yock T, Raney RB. Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer. 2010 Jul 01; 54(7):1045-7. PMID: 20162686; PMCID: PMC3059586.
  69. Yock TI, Yeap BY, Ebb D, MacDonald SM, Pulsifer MB, Marcus KC, Tarbell N. A phase II trial of proton radiotherapy for medulloblastoma: Preliminary results. J Clin Oncol. 2010 Jun 20; 28(18_suppl):CRA9507. PMID: 27937463.
    View in: PubMed
  70. Gensheimer MF, Yock TI, Liebsch NJ, Sharp GC, Paganetti H, Madan N, Grant PE, Bortfeld T. In vivo proton beam range verification using spine MRI changes. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):268-75. PMID: 20472369.
    View in: PubMed
  71. MacDonald SM, Trofimov A, Safai S, Adams J, Fullerton B, Ebb D, Tarbell NJ, Yock TI. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):121-9. PMID: 20452141.
    View in: PubMed
  72. MacDonald SM, Yock TI. Proton beam therapy following resection for childhood ependymoma. Childs Nerv Syst. 2010 Mar; 26(3):285-91. PMID: 20024657.
    View in: PubMed
  73. Hoffman KE, Yock TI. Radiation therapy for pediatric central nervous system tumors. J Child Neurol. 2009 Nov; 24(11):1387-96. PMID: 19841427.
    View in: PubMed
  74. Patel AA, Wolfgang JA, Niemierko A, Hong TS, Yock T, Choi NC. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys. 2009 May 01; 74(1):290-6. PMID: 19362248.
    View in: PubMed
  75. Winkfield KM, Linsenmeier C, Yock TI, Grant PE, Yeap BY, Butler WE, Tarbell NJ. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Mar 01; 73(3):716-21. PMID: 18676089.
    View in: PubMed
  76. Kozak KR, Adams J, Krejcarek SJ, Tarbell NJ, Yock TI. A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys. 2009 May 01; 74(1):179-86. PMID: 19019562.
    View in: PubMed
  77. Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG. Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):69-74. PMID: 18538497.
    View in: PubMed
  78. Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer. 2008 Dec; 62(3):351-5. PMID: 18462828.
    View in: PubMed
  79. MacDonald SM, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap BY, Bortfeld T, Tarbell NJ, Yock T. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):979-86. PMID: 18325681.
    View in: PubMed
  80. Gabeau-Lacet D, Grant E, Stemmer-Rachamimov A, Yock T, Tarbell NJ. Sellar abnormalities in female first-degree relatives. Clin Neurol Neurosurg. 2008 Feb; 110(2):202-6. PMID: 18035480.
    View in: PubMed
  81. Petit JH, Biller BM, Yock TI, Swearingen B, Coen JJ, Chapman P, Ancukiewicz M, Bussiere M, Klibanski A, Loeffler JS. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J Clin Endocrinol Metab. 2008 Feb; 93(2):393-9. PMID: 18029460.
    View in: PubMed
  82. Cochran DM, Yock TI, Adams JA, Tarbell NJ. Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Int J Radiat Oncol Biol Phys. 2008 Apr 01; 70(5):1336-42. PMID: 18029111.
    View in: PubMed
  83. Cunningham MJ, Lin DT, Curry WT, Ebb DH, Yock TI, Curtin HD, Faquin WC. Case records of the Massachusetts General Hospital. Case 20-2007. An 11-year-old boy with a calcified mass in the nose. N Engl J Med. 2007 Jun 28; 356(26):2721-30. PMID: 17596608.
    View in: PubMed
  84. Krejcarek SC, Grant PE, Henson JW, Tarbell NJ, Yock TI. Physiologic and radiographic evidence of the distal edge of the proton beam in craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):646-9. PMID: 17449195; PMCID: PMC1955224.
  85. Liu AK, Marcus KJ, Fischl B, Grant PE, Poussaint TY, Rivkin MJ, Davis P, Tarbell NJ, Yock TI. Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):992-8. PMID: 17379433.
    View in: PubMed
  86. Hagendoorn J, Padera TP, Yock TI, Nielsen GP, di Tomaso E, Duda DG, Delaney TF, Gaissert HA, Pearce J, Rosenberg AE, Jain RK, Ebb DH. Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol. 2006 Dec; 3(12):693-7. PMID: 17139320; PMCID: PMC2693369.
  87. Yock TI, Krailo M, Fryer CJ, Donaldson SS, Miser JS, Chen Z, Bernstein M, Laurie F, Gebhardt MC, Grier HE, Tarbell NJ. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group. J Clin Oncol. 2006 Aug 20; 24(24):3838-43. PMID: 16921035.
    View in: PubMed
  88. Enzinger PC, Yock T, Suh W, Fidias P, Mamon H, Choi N, Lehman N, Lawrence C, Lynch T, Fuchs C. Phase II cisplatin, irinotecan, cetuximab and concurrent radiation therapy followed by surgery for locally advanced esophageal cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):4064. PMID: 27953592.
    View in: PubMed
  89. Gibbs IC, Tuamokumo N, Yock TI. Role of radiation therapy in pediatric cancer. Hematol Oncol Clin North Am. 2006 Apr; 20(2):455-70. PMID: 16730302.
    View in: PubMed
  90. Yock T, Schneider R, Friedmann A, Adams J, Fullerton B, Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 2005 Nov 15; 63(4):1161-8. PMID: 15950401.
    View in: PubMed
  91. Lin AY, Brophy N, Fisher GA, So S, Biggs C, Yock TI, Levitt L. Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. Cancer. 2005 Jan 01; 103(1):119-25. PMID: 15565573.
    View in: PubMed
  92. Yock TI, Tarbell NJ. Technology insight: Proton beam radiotherapy for treatment in pediatric brain tumors. Nat Clin Pract Oncol. 2004 Dec; 1(2):97-103; quiz 1 p following 111. PMID: 16264827.
    View in: PubMed
  93. Yock TI, Taghian AG, Kachnic LA, Coen JJ, Assaad SI, Powell SN. The effect of delaying radiation therapy for systemic chemotherapy on local-regional control in breast cancer. Breast Cancer Res Treat. 2004 Mar; 84(2):161-71. PMID: 14999146.
    View in: PubMed
  94. Yock TI, Zietman AL, Shipley WU, Thakral HK, Coen JJ. Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2002 Oct 01; 54(2):420-6. PMID: 12243817.
    View in: PubMed
  95. Jason LA, Gesten E, Yock T. Relational and behavioral interventions with economically disadvantaged toddlers. Am J Orthopsychiatry. 1976 Apr; 46(2):270-8. PMID: 1266950.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Yock's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_